rosiglitazone has been researched along with Lung Neoplasms in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 16 (69.57) | 29.6817 |
2010's | 7 (30.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Loong, HHF; To, KKW; Wu, WKK | 1 |
Bai, L; Doran, A; Faraji, F; Goldberger, N; Ha, NH; Hu, Y; Hunter, KW; Keane, T; Lee, MP; Shukla, A; Yang, HH | 1 |
Berry, A; D'Acquisto, F; Ianaro, A; Matthews, L; Ray, D; Tersigni, M | 1 |
Buckley, S; Chen, L; Chirieac, LR; Demetri, G; Drapkin, R; Force, J; Girnun, GD; Li, D; Mahmood, U; McNamara, K; Naseri, E; Padera, RF; Silvaggi, J; Spiegelman, BM; Upadhyay, R; Vafai, SB; Weissleder, R; Wong, KK | 1 |
Han, S; Ritzenthaler, JD; Roman, J; Sun, X; Zheng, Y | 1 |
Bonnans, C; Chanez, P; Godard, P; Gras, D; Urbach, V; Vachier, I | 1 |
Clark, OH; Greenspan, FS; Hawkins, R; Kebebew, E; Lindsay, S; Woeber, KA | 1 |
Belinsky, SA; Damiani, LA; Do, KC; Grimes, MJ; Klinge, DM; Lyon, CM; March, TH; Stidley, CA; Thomas, CL | 1 |
Choudhary, R; Li, H; Nemenoff, RA; Sorenson, AL; Weiser-Evans, MC; Winn, RA | 1 |
Amin, J; Crossno, JT; Joyal, T; Li, H; Nemenoff, RA; Poczobutt, J; Sorenson, AL; Sullivan, T; Weiser-Evans, MC | 1 |
Cheng, JT; Chu, ES; Farrell, GC; Li, G; Lo, CM; Man, K; Nie, Y; Shen, B; Sung, JJ; Teoh, N; Wu, CW; Yu, J; Zhao, G | 1 |
Andersen, ME; Chen, Y; Dong, J; Fu, J; Hou, Y; Pi, J; Qu, W; Tokar, EJ; Waalkes, MP; Wang, A; Woods, CG; Xu, Y; Xue, P; Yarborough, K; Zhan, L; Zhang, H; Zhang, Q | 1 |
Buchegger, F; Meier, CA; Petite, C; Philips, JC; Willi, JP | 1 |
Allred, CD; Kilgore, MW | 1 |
Hur, GY; In, KH; Jung, HC; Jung, KH; Kang, KH; Kim, JH; Lee, SY; Shim, JJ; Shin, C; Yoo, SH | 1 |
Hur, GY; In, KH; Jung, HC; Jung, KH; Kang, EJ; Kang, KH; Kim, JH; Lee, SY; Shim, JJ; Shin, C; Yoo, SH | 1 |
Han, S; Roman, J | 1 |
Ahn, JH; Cheon, HG; Kim, KY | 1 |
Ebrahimsade, S; Eckhardt, J; Jäkel, J; Moll, R; Müller, R; Müller-Brüsselbach, S; Peters, JM; Rapp, UR | 1 |
Nemenoff, RA | 1 |
Borenstein, X; Jasnis, MA; Magenta, G; Rolando, R | 1 |
Ghosh, B; Goel, A; Parmar, VS; Prasad, AK; Saini, N | 1 |
Ahmad, S; Chhabra, R; Ghosh, B; Goel, A; Parmar, VS; Prasad, AK; Saini, N | 1 |
1 review(s) available for rosiglitazone and Lung Neoplasms
Article | Year |
---|---|
Peroxisome proliferator-activated receptor-gamma in lung cancer: defining specific versus "off-target" effectors.
Topics: Animals; Antineoplastic Agents; Humans; Lung Neoplasms; Pioglitazone; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2007 |
22 other study(ies) available for rosiglitazone and Lung Neoplasms
Article | Year |
---|---|
PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
Topics: Antineoplastic Agents; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; PPAR gamma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinazolines; Rosiglitazone; Thiazolidinediones | 2018 |
An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes.
Topics: Animals; Cell Adhesion Molecules; Cell Line, Tumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genome-Wide Association Study; Kruppel-Like Transcription Factors; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred NZB; Mice, Transgenic; Nectins; Promyelocytic Leukemia Zinc Finger Protein; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones | 2016 |
Thiazolidinediones are partial agonists for the glucocorticoid receptor.
Topics: Cell Division; Cell Line, Tumor; Dexamethasone; Enzyme Activation; Genes, Reporter; HeLa Cells; Hormone Antagonists; Humans; Luciferases; Lung Neoplasms; Mifepristone; PPAR gamma; Receptors, Glucocorticoid; Rosiglitazone; Thiazolidinediones; Transfection | 2009 |
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Therapy, Combination; ErbB Receptors; Genes, ras; Humans; Hypoglycemic Agents; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Transgenic; PPAR gamma; Protein Kinase Inhibitors; Rosiglitazone; Thiazolidinediones; Uteroglobin | 2008 |
Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Receptors, Nicotinic; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tumor Suppressor Protein p53 | 2009 |
Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor.
Topics: Adenocarcinoma; Anilides; Bronchi; Calcium Signaling; Cell Division; Cell Line, Transformed; Cell Line, Tumor; Chromans; Humans; Hypoglycemic Agents; Lung Neoplasms; PPAR gamma; Receptors, G-Protein-Coupled; Respiratory Mucosa; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Troglitazone | 2009 |
Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer.
Topics: Adult; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; Iodine Radioisotopes; Lung Neoplasms; PPAR gamma; Rosiglitazone; Thiazolidinediones; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms | 2009 |
Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model.
Topics: Adenoma; Animals; Antioxidants; Cell Line, Tumor; Disease Progression; Female; Histone Deacetylases; Humans; Hypoglycemic Agents; Immunohistochemistry; Lung Neoplasms; Mice; Neoplasm Invasiveness; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2009 |
Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail.
Topics: Adenocarcinoma; Blotting, Western; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase 2; Glycogen Synthase Kinase 3; Humans; Hypoglycemic Agents; Lung Neoplasms; Matrix Metalloproteinases; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Snail Family Transcription Factors; Thiazolidinediones; Transcription Factors | 2010 |
Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis.
Topics: Adenocarcinoma; Animals; Bone Marrow; Coculture Techniques; Disease Progression; Fluorescent Antibody Technique; Green Fluorescent Proteins; Humans; Hypoglycemic Agents; Lung Neoplasms; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myeloid Cells; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2011 |
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
Topics: Animals; Biomarkers, Tumor; Blotting, Western; Cadherins; Carcinoma, Hepatocellular; Cell Adhesion; Cell Movement; Chromatin Immunoprecipitation; Gene Expression Profiling; Humans; Hypoglycemic Agents; In Vitro Techniques; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oligonucleotide Array Sequence Analysis; PPAR gamma; Real-Time Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured | 2012 |
Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.
Topics: Antineoplastic Agents; Antioxidant Response Elements; Arsenic Trioxide; Arsenicals; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation; Gene Knockdown Techniques; Glutamate-Cysteine Ligase; Heme Oxygenase-1; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Models, Biological; NAD(P)H Dehydrogenase (Quinone); Neoplastic Stem Cells; NF-E2-Related Factor 2; Oxides; PPAR gamma; Proto-Oncogene Mas; RNA Interference; Rosiglitazone; Thiazolidinediones | 2012 |
Effect of peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, on dedifferentiated thyroid cancers.
Topics: Adult; Aged; Cell Differentiation; Humans; Hypoglycemic Agents; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; PPAR gamma; Prospective Studies; Rosiglitazone; Thiazolidinediones; Thyroglobulin; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed | 2004 |
Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Topics: Alitretinoin; Anilides; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; HT29 Cells; Humans; Ligands; Lung Neoplasms; PPAR gamma; Prostaglandin D2; Retinoid X Receptor alpha; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transfection; Tretinoin | 2005 |
PPAR-gamma agonist increase gefitinib's antitumor activity through PTEN expression.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Dose-Response Relationship, Drug; Gefitinib; Humans; Lung Neoplasms; PPAR gamma; PTEN Phosphohydrolase; Quinazolines; Rosiglitazone; Statistics, Nonparametric; Thiazolidinediones; Tumor Cells, Cultured | 2006 |
Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells.
Topics: Carcinoma, Mucoepidermoid; Cell Line, Tumor; Down-Regulation; Enzyme Inhibitors; ErbB Receptors; Humans; Hypoglycemic Agents; Lung Neoplasms; Mucin 5AC; Mucins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinazolines; Respiratory Mucosa; Rosiglitazone; Smoking; Thiazolidinediones; Tumor Necrosis Factor-alpha; Tyrosine; Tyrphostins | 2006 |
Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
Topics: AMP-Activated Protein Kinases; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Humans; Lung Neoplasms; Multienzyme Complexes; Phosphorylation; PPAR gamma; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2006 |
Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Topics: Apoptosis; Benzhydryl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Epoxy Compounds; Formazans; Humans; Indenes; Lung Neoplasms; Morpholines; PPAR gamma; Proline Oxidase; Reactive Oxygen Species; RNA Interference; Rosiglitazone; Tetrazolium Salts; Thiazolidinediones | 2007 |
Growth of transgenic RAF-induced lung adenomas is increased in mice with a disrupted PPARbeta/delta gene.
Topics: Adenoma; Animals; Gene Expression Regulation, Neoplastic; Genotype; Hypoglycemic Agents; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Transgenic; PPAR delta; PPAR-beta; Proto-Oncogene Proteins c-raf; Rosiglitazone; Thiazolidinediones; Transcription Factors; Transgenes | 2007 |
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Topics: Administration, Oral; Anilides; Animals; Cell Adhesion; Cell Movement; Dose-Response Relationship, Drug; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Nitric Oxide; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured | 2008 |
Apoptogenic effect of 7,8-diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma cell line: role of NF-kappaB, Akt, ROS and MAP kinase pathway.
Topics: Adenocarcinoma; Apoptosis; Caspases; Cell Proliferation; Coumarins; Cytochromes c; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mitochondria; Mitogen-Activated Protein Kinases; NF-kappa B; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured | 2009 |
DAMTC regulates cytoskeletal reorganization and cell motility in human lung adenocarcinoma cell line: an integrated proteomics and transcriptomics approach.
Topics: Actins; Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Cell Line, Tumor; Cell Movement; Coumarins; Cytoskeleton; Humans; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Oncogene Proteins; Protein Deglycase DJ-1; Proteomics; rho GTP-Binding Proteins; rho Guanine Nucleotide Dissociation Inhibitor alpha; Signal Transduction; Transcriptome | 2012 |